Haemophilia: open trials in Japan

12 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT07416604
A Clinical Study to Evaluate the Effects of NXT007 Compared to Emicizumab Prophylaxis in People With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Nara Medical University Hospital, Kashihara-shi · Gunma University Hospital, Maebashi · Nagoya University Hospital, Nagoya · Ogikubo Hospital, Suginami-Ku
Registry updated 2026-11-03
NCT07830732
A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A
Trial Treatment · Phase 3 · Novo Nordisk A/S
Kansai Medical University Hospital_Hematology-Oncology, Hirakata-shi, Osaka · Gunma University Hospital_Hematology, Maebashi-shi, Gunma · Nara Medical University Hospital_Pediatrics, Nara · Niigata Cancer Center Hospital_Department of Internal Medicine, Niigata-shi, Niigata · Hyogo Medical University Hospital_Hematology, Nishinomiya-shi, Hyogo · Tokyo Medical Univ. Hospital_Laboratory Medicine, Tokyo
Registry updated 2026-10-28
NCT05145127
Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
Trial Treatment · Phase 3 · Pfizer
Nagano Children's Hospital, Azumino · Hiroshima University Hospital, Hiroshima · Nara Medical University Hospital, Kashihara · Saitama Medical University Hospital, Lruma-gun · Nagoya University Hospital - Transfusion Medicine, Nagoya · Saga University Hospital, Saga · Saitama Children's Medical Center, Saitama-shi
Registry updated 2026-10-26
NCT07088458
An Observational Study to Learn More About How Well Damoctocog Alfa Pegol Works in Previously Treated Children With Hemophilia A
Research · Bayer
Many Locations, Many Locations
Registry updated 2026-10-26
NCT07416526
A Clinical Study to Evaluate the Effects of NXT007 Compared to Factor VIII Prophylaxis in Participants With Hemophilia A
Trial Treatment · Phase 3 · Hoffmann-La Roche
Nara Medical University Hospital, Kashihara-shi · Tokyo Medical University Hospital, Shinjuku-ku
Registry updated 2026-10-26
NCT06941870
Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Trial Treatment · Phase 4 · Sanofi
Hiroshima · Kawasaki · Saitama · Tokyo
Registry updated 2026-10-15
NCT05611801
A Clinical Trial of Study Medicine (Marstacimab) in Pediatric Patients With Hemophilia A or Hemophilia B
Trial Treatment · Phase 3 · Pfizer
Nagano Children's Hospital, Azumino · Nara Medical University Hospital, Kashihara · Hyogo Prefectural Kobe Children's Hospital, Kobe · Saga University Hospital, Saga · Saitama Prefectural Children's Medical Center, Saitama-Shi
Registry updated 2026-10-14
NCT05568719
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
Trial Treatment · Phase 3 · Pfizer
Saitama Medical University Hospital, Iruma-gun · Nagoya University Hospital, Nagoya · Sapporo Tokushukai Hospital, Sapporo
Registry updated 2026-10-07
NCT07681089
A Phase 2 Study of Foscenvivint in Liver Cirrhosis Patients Caused by HIV/HCV Co-infection With Hemophilia
Trial Treatment · Phase 2 · Kiminori Kimura, MD
Tokyo Metropolitan Komagome Hospital, Bunkyo Ku · National Hospital Organization Osaka National Hospital, Osaka · Hokkaido University Hospital, Sapporo · National Hospital Organization Sendai Medical Center, Sendai
Registry updated 2026-10-05
NCT06461533
A Survey of Susoctocog Alfa (Genetical Recombination) in Participants With Acquired Haemophilia A
Research · Takeda
Tokyo
Registry updated 2026-08-07
NCT06285071
Post-Marketing Surveillance (All Case Surveillance) on Treatment With Alhemo® in Patients With Haemophilia A or Haemophilia B With Inhibitors
Research · Novo Nordisk A/S
Mutsu general hospital_Pediatrics, Aomori · Kyushu university hospital_Pediatrics, Fukuoka · Sapporo Tokushukai Hospital_Pediatrics, Hokkaido · Kagoshima City Hospital_Pediatrics, Kagoshima · St. Marianna University School of Medicine Hospital_Pediatrics, Kanagawa · Hospital of the University of Occupational And Environmental Health Japan_Pediatrics, Kitakyusyu-shi, Fukuoka · Nanbu Medical Center & Children's Medical Center_Hematology and Oncology, Okinawa · University of the Ryukyus Hospital_Endocrinology and Metabolism, Hematology and Rheumatology, Okinawa · Tokyo Medical University Hospital, Tokyo · Ogikubo Hospital_Blood Coagulation, Tokyo · Toshima City
Registry updated 2026-06-15
NCT06831734
Post-marketing Surveillance (Special Use-results Surveillance) on Treatment With Alhemo
Research · Novo Nordisk A/S
Chiba university hospital_Pediatrics, Chiba · National Hospital Organization Awara Hospital_Hematology and Oncology, Fukui · Hoshi General Hospital_Pediatrics, Fukushima · Hyogo Prefectural Amagasaki General Medical Center_Haematology, Hyōgo · St. Marianna University School of Medicine Hospital_Pediatrics, Kanagawa · Saitama Medical Univ. Hospital Saitama medical center_Department of Transfusion Medicine and Cell Therapy, Kawagoe · Miyagi Children's Hospital_Hematology-Oncology, Miyagi · Nagano Children's Hospital_Hematology-Oncology, Nagano · Nagano red cross hospital_Pediatrics, Nahano · Nanbu Medical Center & Children's Medical Center_Pediatric Hematology, Okinawa · Arin Clinic Shonika_Pediatrics, Okinawa · University of the Ryukyus Hospital_Endocrinology and Metabolism, Hematology and Rheumatology, Okinawa · Kansai Medical University Hospital_Pediatrics, Osaka · Fukaya Red Cross Hospital_Haematology, Saitama · Saitama Medical Univ. Hospital Saitama medical center_Department of Transfusion Medicine and Cell Therapy, Saitama · Saitama Children's Med Centre_Hematology-Oncology, Saitama · Matsue red cross hospital_Pediatrics, Shimane · Iwata City Hospital_Haematology, Shizuoka · Hamamatsu Medical Center_Pediatrics, Shizuoka · Ogikubo Hospital_Blood Coagulation, Tokyo · National Center for Child Health and Development_Hematology, Tokyo · Ishiyama Clinic, Yamagata · St. Marianna Univ., Yokohama City Seibu HP, Pediatrics Dept,, Yokohama-shi, Kanagawa
Registry updated 2026-06-15

All Haemophilia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error